Part D Trends For Five-Tier Formularies, Brand-Drug Coinsurance Rising, Analysis Finds
This article was originally published in The Pink Sheet Daily
As Part D open enrollment kicked off Oct. 15, a Kaiser Family Foundation found almost 90% of national and near-national plans use five-tier formularies. And more plans are asking patients to shoulder a higher share of brand drug costs through coinsurance rather than a flat copay.
You may also be interested in...
A review of Part D plan design trends among the leading sponsors shows that Humana has switched to five-tier formularies, UnitedHealth is using a preferred pharmacy network and CVS Caremark is sponsoring plans that include community-based independents in its preferred network.
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.
Busy week for AstraZeneca sees buyout of Acerta and acquisition of remaining Daliresp/Daxas worldwide rights from Takeda. Amgen and GSK undo their cancer drug alliances from 2009 and 2010, with all rights reverting to the big biotech.